Literature DB >> 23291116

Synthesis and structure-activity relationships of harmine derivatives as potential antitumor agents.

Rihui Cao1, Wenxi Fan, Liang Guo, Qin Ma, Guoxian Zhang, Jianru Li, Xuemei Chen, Zhenghua Ren, Liqin Qiu.   

Abstract

Harmine, a naturally occurring β-carboline alkaloid, showed good antitumor activities together with remarkable neurotoxic effects in animal models. In order to search for novel leading compounds endowed with better antitumor activities and less neurotoxicities, a series of harmine derivatives were designed and synthesized by modification of position-2, 7 and 9 of β-carboline nucleus, and their cytotoxic activities against human tumor cell lines were investigated. Acute toxicities and antitumor activities of the selected compounds in mice were also evaluated. Structure-activity relationships studies confirmed that (1) the 7-methoxy structural moiety was the pharmacophore responsible for the neurotoxic effects of this class of compounds; (2) the substituents in position-2 and 9 played a vital role in modulation of their antitumor activities.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23291116     DOI: 10.1016/j.ejmech.2012.11.045

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  11 in total

1.  Development of Kinase-Selective, Harmine-Based DYRK1A Inhibitors that Induce Pancreatic Human β-Cell Proliferation.

Authors:  Kunal Kumar; Peng Wang; Roberto Sanchez; Ethan A Swartz; Andrew F Stewart; Robert J DeVita
Journal:  J Med Chem       Date:  2018-08-21       Impact factor: 7.446

2.  Harmines inhibit cancer cell growth through coordinated activation of apoptosis and inhibition of autophagy.

Authors:  Xinran Geng; Yichang Ren; Fangfang Wang; Danmei Tian; Xinsheng Yao; Youwei Zhang; Jinshan Tang
Journal:  Biochem Biophys Res Commun       Date:  2018-03-01       Impact factor: 3.575

3.  Isoform selectivity of harmine-conjugated 1,2,3-triazoles against human monoamine oxidase.

Authors:  Saqlain Haider; Manal Alhusban; Narayan D Chaurasiya; Babu L Tekwani; Amar G Chittiboyina; Ikhlas A Khan
Journal:  Future Med Chem       Date:  2018-05-23       Impact factor: 3.808

4.  Identification of harmine and β-carboline analogs from a high-throughput screen of an approved drug collection; profiling as differential inhibitors of DYRK1A and monoamine oxidase A and for in vitro and in vivo anti-cancer studies.

Authors:  Michael Tarpley; Helen O Oladapo; Dillon Strepay; Thomas B Caligan; Lhoucine Chdid; Hassan Shehata; Jose R Roques; Rhashad Thomas; Christopher P Laudeman; Rob U Onyenwoke; David B Darr; Kevin P Williams
Journal:  Eur J Pharm Sci       Date:  2021-03-27       Impact factor: 5.112

5.  Synthesis and biological evaluation of novel N9-heterobivalent β-carbolines as angiogenesis inhibitors.

Authors:  Liang Guo; Qin Ma; Wei Chen; Wenxi Fan; Jie Zhang; Bin Dai
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

6.  A First-in-Class TWIST1 Inhibitor with Activity in Oncogene-Driven Lung Cancer.

Authors:  Zachary A Yochum; Jessica Cades; Lucia Mazzacurati; Neil M Neumann; Susheel K Khetarpal; Suman Chatterjee; Hailun Wang; Myriam A Attar; Eric H-B Huang; Sarah N Chatley; Katriana Nugent; Ashwin Somasundaram; Johnathan A Engh; Andrew J Ewald; Yoon-Jae Cho; Charles M Rudin; Phuoc T Tran; Timothy F Burns
Journal:  Mol Cancer Res       Date:  2017-08-29       Impact factor: 5.852

Review 7.  β-Carboline-based molecular hybrids as anticancer agents: a brief sketch.

Authors:  Jay Prakash Soni; Yogesh Yeole; Nagula Shankaraiah
Journal:  RSC Med Chem       Date:  2021-03-24

8.  Prediction of cancer cell sensitivity to natural products based on genomic and chemical properties.

Authors:  Zhenyu Yue; Wenna Zhang; Yongming Lu; Qiaoyue Yang; Qiuying Ding; Junfeng Xia; Yan Chen
Journal:  PeerJ       Date:  2015-11-26       Impact factor: 2.984

9.  Synthesis and mechanisms of action of novel harmine derivatives as potential antitumor agents.

Authors:  Xiao-Fei Zhang; Rong-Qin Sun; Yi-Fan Jia; Qing Chen; Rong-Fu Tu; Ke-Ke Li; Xiao-Dong Zhang; Run-Lei Du; Ri-Hui Cao
Journal:  Sci Rep       Date:  2016-09-14       Impact factor: 4.379

10.  Exploring Kinase Inhibition Properties of 9H-pyrimido[5,4-b]- and [4,5-b]indol-4-amine Derivatives.

Authors:  Yvonnick Loidreau; Carole Dubouilh-Benard; Marie-Renée Nourrisson; Nadège Loaëc; Laurent Meijer; Thierry Besson; Pascal Marchand
Journal:  Pharmaceuticals (Basel)       Date:  2020-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.